Study to Investigate Real Life Effectiveness of Symbicort Maintenance and Reliever Therapy in Asthma Patients Across Asia

Real Life Effectiveness of Symbicort Maintenance and Reliever Therapy (SMART) in Asthma Patients Across Asia: SMARTASIA

The purpose of this study is to compare whether Symbicort Maintenance & Reliever Therapy (SMART) is more effective in uncontrolled asthmatic patients than their current therapy in a real life situation.

Inclusion Criteria:

• Provision of signed informed consent
• Asthma diagnosis at least 6 months before visit 1 of study
• Patients who have reversible airway obstruction continuous asthma treatment except Symbicort at least within 4 weeks before visit 1 of study

Exclusion Criteria:

• Known or suspected allergy to active ingredients of study medication or excipients
• Use of oral, rectal or parenteral glucocorticosteroids 30 days before visit 1 of study
• Smoking, current or previous with a smoking history of ≥ 10 pack years